These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10833475)

  • 21. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiating azathioprine for Crohn's disease.
    Levesque BG; Loftus EV
    Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH
    Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course of Crohn's disease following treatment of lymphoma.
    El Mourabet M; Hashash JG; Sun NH; Issa M; Katz JA; Regueiro M; Barrie AM; Baidoo L; Schwartz MB; Swoger JM; Levesque MC; Binion DG
    Inflamm Bowel Dis; 2011 Jun; 17(6):1265-9. PubMed ID: 21351199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study.
    Qian X; Wang T; Shen J; Ran Z
    Medicine (Baltimore); 2018 Aug; 97(34):e11814. PubMed ID: 30142769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease.
    Etchevers MJ; Aceituno M; Sans M
    World J Gastroenterol; 2008 Sep; 14(36):5512-8. PubMed ID: 18810768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn?].
    García López S
    Gastroenterol Hepatol; 2008 Dec; 31(10):704-5. PubMed ID: 19280773
    [No Abstract]   [Full Text] [Related]  

  • 30. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M; Navarro JT; Ribera JM; Millá F
    Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
    [No Abstract]   [Full Text] [Related]  

  • 33. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I; Mišak Z; Jadrešin O; Močić Pavić A; Kolaček S
    Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
    Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
    Hazlewood GS; Rezaie A; Borman M; Panaccione R; Ghosh S; Seow CH; Kuenzig E; Tomlinson G; Siegel CA; Melmed GY; Kaplan GG
    Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
    D'Haens GR; Vermeire S; Van Assche G; Noman M; Aerden I; Van Olmen G; Rutgeerts P
    Gastroenterology; 2008 Oct; 135(4):1123-9. PubMed ID: 18727929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease.
    Mendoza JL; Urcelay E; Lana R; Martín MC; López N; Guijarro LG; Mayol JA; Taxonera C; de la Concha EG; Peña AS; Díaz-Rubio M
    Inflamm Bowel Dis; 2007 May; 13(5):585-90. PubMed ID: 17262810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
    Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.